PD1 inhibitor in combination with 5-azacytidine and low-dose DLI for the successful treatment of AML patients who relapsed after transplantation

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Bone marrow transplantation (Basingstoke) 2021-05, Vol.56 (5), p.1003-1005
Hauptverfasser:	Qian, Chong-Sheng, Ma, Xiao, Wang, Jin, Wang, Ting-Jing, Bai, Lian, Zhou, Hai-Xia, Xu, Ming-Zhu, Sun, Ai-Ning, Wu, De-Pei, Liu, Song-Bai, Xue, Sheng-Li
Format:	Artikel
Sprache:	eng
Schlagworte:	13/1 13/31 631/67/1990/283/1897 692/699/1541/1990/283/1897 Azacytidine Blood diseases Bone marrow Case studies Cell Biology Enzyme inhibitors Hematology Internal Medicine Leukemia Lymphocytes Medicine Medicine & Public Health Patient outcomes Patients PD-1 protein Perspective Public Health Remission (Medicine) Stem cell transplantation Stem Cells Transplantation
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!